A. Alonso

473 total citations · 1 hit paper
8 papers, 272 citations indexed

About

A. Alonso is a scholar working on Surgery, Oncology and Physiology. According to data from OpenAlex, A. Alonso has authored 8 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Oncology and 2 papers in Physiology. Recurrent topics in A. Alonso's work include CAR-T cell therapy research (2 papers), Tumors and Oncological Cases (1 paper) and Peptidase Inhibition and Analysis (1 paper). A. Alonso is often cited by papers focused on CAR-T cell therapy research (2 papers), Tumors and Oncological Cases (1 paper) and Peptidase Inhibition and Analysis (1 paper). A. Alonso collaborates with scholars based in Spain, United States and France. A. Alonso's co-authors include Rao Prabhala, Kristen Hege, Kenneth C. Anderson, Adam S. Sperling, Fabio Petrocca, Hervé Avet‐Loiseau, Yu‐Tzu Tai, Abdul Hamid Bazarbachi, Mehmet Samur and Nikhil C. Munshi and has published in prestigious journals such as Nature Communications, Cancer Research and European Journal of Applied Physiology.

In The Last Decade

A. Alonso

8 papers receiving 267 citations

Hit Papers

Biallelic loss of BCMA as a resistance mechanism to CAR T... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Alonso Spain 5 198 118 109 69 40 8 272
Estefanía García‐Guerrero Spain 10 140 0.7× 113 1.0× 70 0.6× 59 0.9× 36 0.9× 19 264
Myo Htut United States 8 144 0.7× 70 0.6× 75 0.7× 53 0.8× 28 0.7× 13 172
Sandra B. Horowitz United States 9 227 1.1× 77 0.7× 78 0.7× 65 0.9× 49 1.2× 14 305
Marion Subklewe Germany 10 212 1.1× 71 0.6× 66 0.6× 65 0.9× 35 0.9× 24 257
Tonia Nesheiwat United States 9 153 0.8× 110 0.9× 75 0.7× 37 0.5× 28 0.7× 22 195
Xugeng Wang China 4 107 0.5× 59 0.5× 64 0.6× 46 0.7× 19 0.5× 5 141
Yunsi Olyslager United States 8 153 0.8× 100 0.8× 108 1.0× 28 0.4× 23 0.6× 14 180
Ana Alarcón Tomás United States 8 177 0.9× 50 0.4× 33 0.3× 42 0.6× 52 1.3× 22 233
Hsin‐Yuan Cheng United States 9 138 0.7× 155 1.3× 33 0.3× 158 2.3× 22 0.6× 15 345
Lauren S. Riley United States 6 333 1.7× 97 0.8× 28 0.3× 122 1.8× 96 2.4× 6 440

Countries citing papers authored by A. Alonso

Since Specialization
Citations

This map shows the geographic impact of A. Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Alonso more than expected).

Fields of papers citing papers by A. Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Alonso. The network helps show where A. Alonso may publish in the future.

Co-authorship network of co-authors of A. Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of A. Alonso. A scholar is included among the top collaborators of A. Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Alonso. A. Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hanna, Glenn J., Robert Redd, A. Alonso, et al.. (2022). Abstract CT540: A phase 1 trial of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy with IL-15 superagonist in advanced head and neck cancer: Part 1 results. Cancer Research. 82(12_Supplement). CT540–CT540. 3 indexed citations
2.
Samur, Mehmet, Mariateresa Fulciniti, Anıl Aktaş Samur, et al.. (2021). Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma. Nature Communications. 12(1). 868–868. 236 indexed citations breakdown →
3.
Sauvet, Fabien, Cyprien Bourrilhon, Yves Besnard, et al.. (2012). Effects of 29-h total sleep deprivation on local cold tolerance in humans. European Journal of Applied Physiology. 112(9). 3239–3250. 12 indexed citations
4.
Alonso, A., et al.. (2004). Implantación de una historia clínica informatizada: encuesta sobre el grado de utilización y satisfacción en un hospital terciario. Anales del Sistema Sanitario de Navarra. 27(2). 233–9. 6 indexed citations
5.
Abad, Cipriano, et al.. (1996). Inflammatory extracavitary right atrial mass and pulmonary thromboembolism.. PubMed. 37(4). 413–5. 2 indexed citations
6.
Gallo, Ignacio, Cristina Alonso, Iñaki Lekuona, et al.. (1991). In situ right gastroepiploic artery A conduit for coronary revascularization. European Journal of Cardio-Thoracic Surgery. 5(1). 34–36. 2 indexed citations
7.
Alonso, A., et al.. (1980). Congenital medulloblastoma. Report of two cases. Pediatric Radiology. 9(1). 5–10. 7 indexed citations
8.
Alonso, A., et al.. (1979). Intracranial calcification in a neonate with the Sturge Weber Syndrome and additional problems. Pediatric Radiology. 8(1). 39–41. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026